RECURSION LONDON LTD

Active Altrincham

Research and experimental development on biotechnology

11 employees website.com
Research and experimental development on biotechnology
R

RECURSION LONDON LTD

Research and experimental development on biotechnology

Founded 5 Jun 2020 Active Altrincham, United Kingdom 11 employees website.com
Research and experimental development on biotechnology

Previous Company Names

CYCLICA LTD 5 Jun 2020 — 26 Mar 2024
Accounts Submitted 2 Jan 2026 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 12 Jun 2025 Next due 18 Jun 2026 2 months remaining
Net assets £188K £573K 2024 year on year
Total assets £4M
Total Liabilities £3M £3M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for RECURSION LONDON LTD (12648333), an active company based in Altrincham, United Kingdom. Incorporated 5 Jun 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£653.33k

Net Assets

£188.02k

Increased by £573.13k (+149%)

Total Liabilities

£3.47M

Increased by £3.09M (+802%)

Turnover

£4.87M

Employees

11

Increased by 10 (+1000%)

Debt Ratio

95%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Recursion Pharmaceuticals, Inc
100.0%
1
Cyclica Therapeutics Inc
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Recursion Pharmaceuticals, Inc.

United States Of America

Active
Notified 25 May 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

RECURSION LONDON LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Jan 2026AccountsAnnual accounts made up to 2024-12-31
12 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-04 with updates
25 Feb 2025OfficersAppointment of Mr Nathan Ben Hatfield as director on 2025-02-11
25 Feb 2025OfficersAppointment of Mr Ben Roberts Taylor as director on 2025-02-11
10 Feb 2025OfficersTermination of Michael David Secora as director on 2024-12-31
2 Jan 2026 Accounts

Annual accounts made up to 2024-12-31

12 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-04 with updates

25 Feb 2025 Officers

Appointment of Mr Nathan Ben Hatfield as director on 2025-02-11

25 Feb 2025 Officers

Appointment of Mr Ben Roberts Taylor as director on 2025-02-11

10 Feb 2025 Officers

Termination of Michael David Secora as director on 2024-12-31

Recent Activity

Latest Activity

Annual accounts made up to 2024-12-31

3 months ago on 2 Jan 2026

Confirmation statement made on 2025-06-04 with updates

10 months ago on 12 Jun 2025

Appointment of Mr Nathan Ben Hatfield as director on 2025-02-11

1 years ago on 25 Feb 2025

Appointment of Mr Ben Roberts Taylor as director on 2025-02-11

1 years ago on 25 Feb 2025

Termination of Michael David Secora as director on 2024-12-31

1 years ago on 10 Feb 2025